![Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-01544-4/MediaObjects/41598_2021_1544_Fig6_HTML.png)
Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports
![Figure 1 from Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. | Semantic Scholar Figure 1 from Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1b53b0e40155294da80c8a296f2ce73114da70ed/2-Figure1-1.png)
Figure 1 from Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. | Semantic Scholar
![HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6606092/MediaObjects/41416_2011_Article_BF6606092_Fig1_HTML.jpg)
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
![Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-01544-4/MediaObjects/41598_2021_1544_Fig1_HTML.png)
Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports
![Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population](https://www.mdpi.com/cancers/cancers-14-02124/article_deploy/html/images/cancers-14-02124-g001.png)
Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
![Comparison of the median levels of serum HE4 and CA125 according to... | Download Scientific Diagram Comparison of the median levels of serum HE4 and CA125 according to... | Download Scientific Diagram](https://www.researchgate.net/publication/346512811/figure/tbl2/AS:1023954877698051@1621141275206/Comparison-of-the-median-levels-of-serum-HE4-and-CA125-according-to-prognostic-factors.png)
Comparison of the median levels of serum HE4 and CA125 according to... | Download Scientific Diagram
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
![The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65353-x/MediaObjects/41598_2020_65353_Fig1_HTML.png)
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
![PDF) Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine PDF) Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine](https://i1.rgstatic.net/publication/356069953_Recurrence_monitoring_for_ovarian_cancer_using_a_cell_phone-integrated_paper_device_to_measure_the_ovarian_cancer_biomarker_HE4CRE_ratio_in_urine/links/618b594dd7d1af224bd01111/largepreview.png)
PDF) Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine
![Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma](https://www.mdpi.com/sensors/sensors-21-03567/article_deploy/html/images/sensors-21-03567-g001.png)
Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma
![PDF) Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine PDF) Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine](https://www.researchgate.net/publication/356069953/figure/fig3/AS:1088467652087816@1636522319109/Comparison-of-mean-values-for-HE4-CRE-ratios-for-scanner-and-cellphone-to-actual-values_Q320.jpg)
PDF) Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine
![Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-01544-4/MediaObjects/41598_2021_1544_Fig3_HTML.png)